Elevated antibody levels against Chlamydia, Borrelia and Ehrlichia cannot discriminate patients with axial spondyloarthritis from non-specific low back pain

Louise Thuesen Hermansen, Anne Gitte Loft, Alice Christiansen, Leona Gilbert, Kunal Garg, Kati Karvonen, Anne Grethe Jurik, Ulrich Weber, Bodil Arnbak, Claus Manniche, Tue Secher Jensen, Mikkel Østergaard, Susanne Juhl Pedersen, Torben Barington, Hans Jørn Kolmos, Kim Hørslev-Petersen, Oliver Hendricks

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date6. Oct 2016
Publication statusPublished - 6. Oct 2016
Event25th Meeting of the Paul-Ehrlich-Society, Infektiologie Update 2016 - University of Rostock, Rostock, Germany
Duration: 6. Oct 20168. Oct 2016

Conference

Conference25th Meeting of the Paul-Ehrlich-Society, Infektiologie Update 2016
LocationUniversity of Rostock
CountryGermany
CityRostock
Period06/10/201608/10/2016

Cite this

Hermansen, L. T., Loft, A. G., Christiansen, A., Gilbert, L., Garg, K., Karvonen, K., Jurik, A. G., Weber, U., Arnbak, B., Manniche, C., Jensen, T. S., Østergaard, M., Pedersen, S. J., Barington, T., Kolmos, H. J., Hørslev-Petersen, K., & Hendricks, O. (2016). Elevated antibody levels against Chlamydia, Borrelia and Ehrlichia cannot discriminate patients with axial spondyloarthritis from non-specific low back pain. Poster session presented at 25th Meeting of the Paul-Ehrlich-Society, Infektiologie Update 2016, Rostock, Germany.